Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Research paper from Europe PMC. Evidence status: source reported.

Published

2022-02-01

Source reference

MED:35151397

DOI

10.1016/s0140-6736(22)00163-5

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

RECOVERY Collaborative Group. · Lancet · research support, non-u.s. gov't; research-article; adaptive clinical trial; randomized controlled trial; journal article · Found via: ClinicalTrials.gov result publication

Source: https://europepmc.org/article/MED/35151397. Captured 2026-10-24.

Limitations: Listed by a ClinicalTrials.gov registration as a result publication of that study, and fetched by its PubMed ID. The registry's listing is the sponsor's statement; it does not confirm which data the paper used. Preprints may not be peer reviewed.